CFO of Antigenics Inc. (AGEN, Financial) Shalini Sharp sells 1,520 shares of AGEN on 07/27/2010 at an average price of $0.93 a share.
Antigenics Inc. has a market cap of $85.8 million; its shares were traded at around $0.9112 with and P/S ratio of 25.7.
AGEN is in the portfolios of Jim Simons of Renaissance Technologies LLC.
Antigenics Inc. has a market cap of $85.8 million; its shares were traded at around $0.9112 with and P/S ratio of 25.7.
AGEN is in the portfolios of Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell: Chairman & CEO Garo H Armen sold 87,628 shares of AGEN stock on 03/11/2010 at the average price of 0.79. Garo H Armen owns at least 1,595,855 shares after this. The price of the stock has increased by 15.34% since.
CFO Recent Trades:
- Sell: CFO Shalini Sharp sold 1,950 shares of AGEN stock on 04/27/2010 at the average price of 1.16. Shalini Sharp owns at least 238,868 shares after this. The price of the stock has decreased by 21.45% since.
Directors and Officers Recent Trades:
- Buy: Director Timothy Wright bought 10,000 shares of AGEN stock on 05/18/2010 at the average price of 1.34. Timothy Wright owns at least 10,000 shares after this. The price of the stock has decreased by 32% since.
- Sell: VP, Clin, Reg & Quality Kerry Wentworth sold 4,165 shares of AGEN stock on 04/26/2010 at the average price of 1.21. Kerry Wentworth owns at least 140,539 shares after this. The price of the stock has decreased by 24.69% since.
- Sell: VP, Finance Christine M Klaskin sold 2,500 shares of AGEN stock on 04/26/2010 at the average price of 1.21. Christine M Klaskin owns at least 69,683 shares after this. The price of the stock has decreased by 24.69% since.
- Sell: VP and General Counsel Karen Valentine sold 29,039 shares of AGEN stock on 03/16/2010 at the average price of 0.76. Karen Valentine owns at least 51,491 shares after this. The price of the stock has increased by 19.89% since.
